Latest News

Filters

Filter by tags: Electron Radiopharmaceutical Food and Drug Administration Clear all tag filters

1 news articles found


Belgium’s (Ion Beam Applications (IBA), a leading provider of proton therapy solutions for the treatment of cancer, and US-based NorthStar Medical Radioisotopes, which produces radiopharmaceuticals used for medical imaging and therapeutic applications, on 8 March announced a collaboration to increase global availability of technetium-99m (Tc-99m), the most widely used medical radioisotope. The collaboration enables companies outside the USA to access the Tc-99m Generation Systems (TCM Generation Systems) that utilise NorthStar’s proprietary non-uranium based Mo-99 produced using IBA’s accelerators and beamlines. 

Date: Tuesday, 16 March 2021
Original article: neimagazine.com/news/newsiba-and-northstar-medical-radioisotopes-expand-collaboration-8601282

Status

No Tags found.